Skip to main content
Premium Trial:

Request an Annual Quote

Recommendation Explanations

The US Centers for Disease Control and Prevention is struggling to make and communicate recommendations based on limited data, the New York Times reports.

It notes that the CDC in typical times is a slow-moving federal agency that pores over data before making recommendations, an approach that has been upended by the COVID-19 pandemic and the fast emergence of SARS-CoV-2 variants. As the agency has tried to speed its response, the Times says it has led to confusing recommendations, such as the recent change in recommended isolation time after infection from 10 days to five days, if not symptomatic, which critics said had little supporting evidence. The guidelines further said a test was not needed to leave isolation.

Former CDC Director Thomas Frieden tells the Times that the new isolation recommendations are "basically correct." But he adds that "the problem is, they were not explained."

The Times says that that CDC Director Rochelle Walensky has since appeared at news briefings to better communicate the reason for the change. It reported earlier this month that Walensky said at one that the change was "grounded in science" and a review of when people were most infectious, though that she noted much of the data was from earlier variants, not Omicron.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.